Rapamycin Enhances CAR-T Control of HIV Replication and Reservoir Elimination in vivo

By sjmartinez • February 12, 2025

Mu W, Tomer S, Harding J, Kedia N, Rezek V, Cook E, Patankar V, Carrillo MA, Martin H, Ng HL, Wang L, Marsden MD, Kitchen SD, Zhen A. Rapamycin Enhances CAR-T Control of HIV Replication and Reservoir Elimination in vivo. J Clin Invest. 2025 Feb 11:e185489. doi: 10.1172/JCI185489. Epub ahead of print. PMID: 39932788.

Tags: AIDS/HIV, Hematology/Oncology, Immunology, immunotherapy, Post Doc, Publications, T cells

Related Posts

Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study

Milhem MM, Zakharia Y, Davar D, Buchbinder EI, Medina T, Daud A, Ribas A, Chmielowski B, Niu J, Gibney GT, Margolin K, Olszanski AJ, Mehmi[...]

The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment

Chan SL, Sun HC, Xu Y, Zeng H, El-Serag HB, Lee JM, Schwartz ME, Finn RS, Seong J, Wang XW, Paradis V, Abou-Alfa GK, Rimassa[...]

SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinoma

Powles TB, Grande E, Alimohamed N, Oliveira N, Sridhar SS, Drakaki A, Kanesvaran R, Loriot Y, Necchi A, Franco S, Jiang D, Apolinario K, Zhang[...]